J&J: Biosimilars will not replicate generic levels of competition or substitution
Biosimilars will help sustain biopharma innovation but will not erode sales like generic drugs, J&J’s CEO Alex Gorsky told investors last week.
Archives for September 14, 2015
Merck Serono invests €65m in bio R&D
Merck (EMD) Serono, the biopharmaceutical division of Merck KGaA, is building a €65m R&D lab for 200 staff in Darmstadt, Germany.